Jane Street
BBC icon

Jane Street’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Jane Street’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,575
Closed -$315K – 11536
2026
Q1 		$315K Sell
7,575
-353
-4% -$14.5K ﹤0.01% 9134
2025
Q4 		$306K Sell
7,928
-25,299
-76% -$859K ﹤0.01% 8804
2025
Q3 		$907K Buy
+33,227
New +$758K ﹤0.01% 6517
2025
Q2 		– Sell
-21,149
Closed -$371K – 9609
2025
Q1 		$371K Buy
+21,149
New +$454K ﹤0.01% 7443
2020
Q1 		– Sell
-36,323
Closed -$1.38M – 5289
2019
Q4 		$1.38M Buy
36,323
+9,372
+35% +$279K ﹤0.01% 2367
2019
Q3 		$642K Buy
26,951
+7,409
+38% +$201K ﹤0.01% 3199
2019
Q2 		$563K Sell
19,542
-13,966
-42% -$390K ﹤0.01% 3427
2019
Q1 		$954K Buy
+33,508
New +$878K ﹤0.01% 2860
2018
Q4 		– Sell
-22,650
Closed -$783K – 4924
2018
Q3 		$783K Buy
22,650
+9,268
+69% +$313K ﹤0.01% 3069
2018
Q2 		$437K Buy
13,382
+3,147
+31% +$103K ﹤0.01% 3731
2018
Q1 		$336K Sell
10,235
-13,851
-58% -$452K ﹤0.01% 3895
2017
Q4 		$685K Buy
+24,086
New +$674K ﹤0.01% 2801
2017
Q2 		– Sell
-32,219
Closed -$747K – 4314
2017
Q1 		$747K Buy
32,219
+4,718
+17% +$100K ﹤0.01% 2429
2016
Q4 		$506K Buy
27,501
+589
+2% +$11.7K ﹤0.01% 2851
2016
Q3 		$610K Buy
26,912
+11,380
+73% +$233K ﹤0.01% 2547
2016
Q2 		$280K Buy
+15,532
New +$305K ﹤0.01% 3402
2015
Q4 		– Sell
-17,855
Closed -$471K – 3978
2015
Q3 		$471K Sell
17,855
-39,267
-69% -$1.33M ﹤0.01% 2361
2015
Q2 		$2.07M Buy
57,122
+39,905
+232% +$1.37M 0.01% 985
2015
Q1 		$565K Buy
17,217
+4,459
+35% +$136K ﹤0.01% 1940
2014
Q4 		$354K Buy
+12,758
New +$350K ﹤0.01% 1752

Other funds holding BBC

KCP
Kera Capital Partners San Jose, California $1.04B AUM 52.56% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jane Street's BBC Position: Q2 2026 in Review

Jane Street sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2026, closing a stake of 7,575 shares — an estimated $315K sold.

Jane Street first reported a position in BBC in Q4 2014 and held it in 20 quarters. The position peaked at $2.07M in Q2 2015. 20 funds tracked by Wall St. Rank hold BBC as of Q2 2026.

  • Jane Street reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 7,575 Virtus Biotech Clinical Trials ETF shares in Q2 2026, an estimated $315K.
  • Jane Street first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2014 and held it in 20 quarters.
  • Jane Street's Virtus Biotech Clinical Trials ETF position peaked at $2.07M in Q2 2015.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.